| |
UNITED STATES |
OMB APPROVAL |
| |
SECURITIES AND EXCHANGE COMMISSION |
OMB Number: |
3235-0058 |
| |
Washington, D.C. 20549 |
Expires: |
April 30, 2025 |
| |
|
Estimated average burden |
| |
FORM 12b-25 |
hours per response |
2.50 |
| |
NOTIFICATION OF LATE FILING |
SEC FILE NUMBER |
| 001-41139 |
| |
|
CUSIP NUMBER |
| |
|
123013104 |
| (Check One): |
¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR |
| |
For Period Ended: June 30, 2025 |
| |
¨ |
Transition Report on Form 10-K |
| |
¨ |
Transition Report on Form 20-F |
| |
¨ |
Transition Report on Form 11-K |
| |
¨ |
Transition Report on Form 10-Q |
| |
For the Transition Period Ended: _______________ |
|
Read Instruction (on back page) Before Preparing
Form. Please Print or Type.
Nothing in this form shall be construed to imply
that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART I – REGISTRANT INFORMATION
Alchemy
Investments Acquisition Corp 1
Full Name of Registrant
Former Name if Applicable
850 Library Avenue, Suite 204-F
Address of Principal Executive Office (Street and Number)
Newark, DE 19711
City, State and Zip Code
PART II – RULES 12b-25(b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box
if appropriate)
| |
(a) |
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| x |
(b) |
The subject annual report, semi-annual report, transition report on Form 10-K, Form 10-Q, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| |
(c) |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III – NARRATIVE
State below in reasonable detail why Forms 10-K,
20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time
period.
ALCHEMY INVESTMENTS ACQUISITION CORP 1. (the “Company”)
has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended
June 30, 2025 (the “Quarterly Report”) by the prescribed due date.
The Company is working diligently to file the
Quarterly Report as soon as practicable and expects to file the Quarterly Report within five calendar days of the prescribed due date.
(Attach extra Sheets if Needed)
PART IV – OTHER INFORMATION
| (1) |
Name and telephone number of person to contact in regard to this notification |
| |
Mattia Tomba |
|
212 |
|
877-1588 |
| |
(Name) |
|
(Area Code) |
|
(Telephone Number) |
| (2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). |
| |
|
Yes x
No ¨ |
| |
|
|
| (3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |
| |
|
Yes ¨
No x |
| |
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. |
Alchemy
Investments Acquisition Corp 1
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
| Date |
August 15, 2025 |
|
By |
/s/ Mattia Tomba |
| |
|
|
Mattia Tomba |
| |
|
|
Chief Executive Officer |
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed
beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive
officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
| |
ATTENTION |
|
| |
|
| Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). |
